WDNA
WisdomTree BioRevolution Fund
Price Chart
Latest Quote
$23.15
-0.03 (-0.15%)
Current Price
| Previous Close | $23.19 |
| Open | $22.86 |
| Day High | $23.15 |
| Day Low | $22.40 |
| Volume | 2,052 |
Fund Information
| Quarterly Dividend / Yield | N/A / 3.97% |
| Net Assets | $2.52M |
| Expense Ratio | 0.45% |
| Category | Health |
| Fund Family | WisdomTree |
| Net Asset Value | $23.78 |
| Premium/Discount | -2.65% |
| Quarterly Dividend Yield | 3.97% |
| P/E Ratio | 28.14 |
| Exchange | BTS |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $21.95 |
| SMA50 | $20.84 |
| SMA200 | $18.34 |
| RSI | 64.07 |
| ATR | 0.6381 |
| Rel Volume | 0.59 |
Performance History
| Week | -2.18% |
| Month | +16.29% |
| Quarter | +26.27% |
| 6 Months | +26.69% |
| YTD | +36.82% |
| Year | +68.20% |
| 3 Years | +49.29% |
| 5 Years | -5.17% |
| 10 Years | -1.24% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-08-31 | $23.15 | 2,100 |
| 2026-08-27 | $23.84 | 400 |
| 2026-08-26 | $23.90 | 20,900 |
| 2026-08-25 | $24.08 | 6,000 |
| 2026-08-24 | $23.24 | 2,600 |
| 2026-08-21 | $23.67 | 10,300 |
| 2026-08-20 | $23.20 | 4,600 |
| 2026-08-19 | $23.99 | 8,000 |
| 2026-08-18 | $21.38 | 2,900 |
| 2026-08-17 | $21.45 | 1,600 |
| 2026-08-14 | $21.13 | 100 |
| 2026-08-13 | $21.23 | 1,200 |
| 2026-08-12 | $21.37 | 200 |
| 2026-08-11 | $21.23 | 1,500 |
| 2026-08-10 | $21.23 | 400 |
| 2026-08-07 | $20.87 | 2,800 |
| 2026-08-06 | $20.30 | 200 |
| 2026-08-05 | $20.22 | 700 |
| 2026-08-04 | $19.95 | 300 |
| 2026-08-03 | $19.52 | 3,800 |
About WisdomTree BioRevolution Fund
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
đ° Latest News
No news articles available at the moment. Check back later for updates on WDNA.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.